Dedicated to addressing the unmet clinical needs in the field of refractory tumors such as urinary and digestive tract tumors
A rich R&D pipeline with multiple independent research and development and innovative drugs with global intellectual property rights
Accelerate to bring more innovative therapies to patients
Norroy has an independent platform for proprietary technology. This platform integrates nuclear medicine technology, high-throughput screening,
The Wuxi base of Norroy is scheduled to be operational by 2023, encompassing a total construction area of approximately 3000 square meters.
Norroy possesses a comprehensive expertise from drug discovery to commercialization of nuclear medicine, supported by a highly skilled and experienced professional team.
Address: No.35-208, Changjiangnan Road, XinWu District, Wuxi, China
Mail address: bd@norroybioscience.com
Website: www.norroybioscience.com
86-0510-88786189
